Pharma Nobis
Pharma Nobis, a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across various regions. Founded in 2010, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a focus on delivering innovative solutions, Pharma Nobis offers a diverse portfolio of products, including oral solid dosage forms and complex formulations. Their commitment to quality and regulatory compliance sets them apart in a competitive market. Recognised for their operational excellence, Pharma Nobis has achieved significant milestones, including successful partnerships and a robust pipeline of products. As they continue to expand their market presence, Pharma Nobis remains dedicated to improving patient outcomes through accessible and effective medications.
DitchCarbon Score
How does Pharma Nobis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharma Nobis's score of 3 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharma Nobis's reported carbon emissions
Pharma Nobis, headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that Pharma Nobis may still be in the early stages of formalising its climate commitments or reporting its emissions. In the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to set ambitious targets to reduce their carbon footprint. As the industry evolves, it will be crucial for Pharma Nobis to establish clear climate strategies and transparent reporting to align with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharma Nobis is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
